Back
Oxford BioMedica PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Buy
60
OXBDF
Oxford BioMedica PLC
Last Price:
3.86
Seasonality Move:
15.01%
Sell
50
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.12
Seasonality Move:
3.75%
Buy
60
Oxford BioMedica PLC (OXBDF)
is a Buy
Is Oxford BioMedica PLC a Buy, Sell or Hold?
- The current Oxford BioMedica PLC [OXBDF] share price is $3.86. The Score for OXBDF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- OXBDF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.12. The Score for ADAP is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OXBDF Stock Price Chart
What is Oxford BioMedica PLC's stock price today?
-
The Oxford BioMedica PLC share price today is $3.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OXBDF is experiencing slight buying pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
OXBDF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 96.47 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.5 - 3.54) | Buy |
| Bollinger Bands (100): | (2.19 - 2.97) | Buy |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 44.88 | Sell |
| Chaikin Money Flow: | -203508 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.24) | Sell |
| Bollinger Bands (100): | (0.81 - 1.47) | Sell |
OXBDF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.72 | Buy |
| 20-day SMA: | 3.12 | Buy |
| 50-day SMA: | 2.75 | Buy |
| 200-day SMA: | 3.04 | Buy |
| 8-day EMA: | 3.67 | Buy |
| 20-day EMA: | 3.28 | Buy |
| 50-day EMA: | 2.89 | Buy |
| 200-day EMA: | 3.21 | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.15 | Sell |
| 20-day SMA: | 1.09 | Buy |
| 50-day SMA: | 1.31 | Sell |
| 200-day SMA: | 0.91 | Buy |
| 8-day EMA: | 1.13 | Sell |
| 20-day EMA: | 1.15 | Sell |
| 50-day EMA: | 1.2 | Sell |
| 200-day EMA: | 1.09 | Buy |
Oxford BioMedica PLC Earnings Growth & OXBDF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.08 per share.
Oxford BioMedica PLC Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||